Monoclonal Antibodies No Longer Effective Against New Strains of SARS-CoV-2
Monoclonal antibodies, which are synthetic versions of antibodies that are produced in a lab, appear to have lost effectiveness against COVID-19 disease as new variants of the virus emerge. Previously touted as the top-of-the-line outpatient treatment by public health officials and many clinicians, monoclonal antibodies have fallen out of favor as outpatient treatment for patients […]
Treatment Protocols for COVID-19: An Overview
Two years into the global pandemic of the novel coronavirus SARS-CoV-2, there is scant guidance from government agencies, universities, or professional medical organizations to help individuals recover from the SARS-CoV-2 infection that causes COVID-19 without the need for hospitalization. The U.S. Centers for Disease Control and Prevention (CDC), which recommends monoclonal antibodies for high-risk individuals […]